Skip to content

Clinical trials

ST Elevation Myocardial Infarction trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: ST Elevation Myocardial Infarction Country / region: Taiwan Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20161
20184
20211
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abbott Medical Devices1
Biosensors Europe SA1
Chang Gung Memorial Hospital1
China Medical University Hospital1
Daiichi Sankyo Taiwan Ltd., a Daiichi Sankyo Company1
Ever Supreme Bio Technology Co., Ltd.1
Far Eastern Memorial Hospital1
GlaxoSmithKline1
Novartis Pharmaceuticals1
Taipei Medical University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
ST Elevation Myocardial Infarction10
Non-ST Elevated Myocardial Infarction4
Acute Coronary Syndrome3
Angina, Unstable2
Cardiovascular Diseases2
Atherosclerosis1
Coronary Artery Disease1
Coronary Stenosis1
Dyslipidemias1
Myocardial Infarction1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.